Quadient S.A. reiterated consolidated earnings guidance for the fiscal year 2022. For the year, the company's organic revenue growth confirmed above 2% compared to fiscal year 2021. Current EBIT organic growth confirmed at low to mid-single digit compared to fiscal year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.84 EUR | +1.64% | +6.21% | +3.23% |
May. 09 | Quadient wins US healthcare contracts | CF |
May. 09 | Quadient Wins New US Contracts for Communication Software in Q1 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.23% | 741M | |
+5.34% | 35.9B | |
+4.27% | 15.76B | |
-6.76% | 9.06B | |
+0.05% | 7.09B | |
+14.48% | 5.54B | |
-46.16% | 4.48B | |
+7.76% | 2.9B | |
-15.24% | 2.32B | |
+0.38% | 2.29B |
- Stock Market
- Equities
- QDT Stock
- News Quadient S.A.
- Quadient S.A. Reiterates Consolidated Earnings Guidance for the Fiscal Year 2022